Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of postoperative pain and anxiety after lumbar surgery
ChiCTR2200060138Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in acute postoperative pain and anxiety disorder (3 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: Visual analogue of pain without activity, Visual analogue of anxiety and 1 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
acute postoperative painanxiety disorder
Beyond the preview
Go deeper on ChiCTR2200060138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060138.